SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,724 | -47.2% | 19,517 | -29.2% | 0.00% | – |
| Q2 2023 | $128,224 | -44.7% | 27,575 | -45.0% | 0.00% | – |
| Q1 2023 | $231,753 | +404.1% | 50,163 | +781.6% | 0.00% | – |
| Q4 2022 | $45,975 | +474.7% | 5,690 | +331.7% | 0.00% | – |
| Q3 2022 | $8,000 | -42.9% | 1,318 | -52.1% | 0.00% | – |
| Q2 2022 | $14,000 | -95.5% | 2,752 | -92.8% | 0.00% | – |
| Q1 2022 | $313,000 | -59.7% | 38,109 | -27.0% | 0.00% | – |
| Q4 2021 | $777,000 | -63.6% | 52,217 | -53.7% | 0.00% | – |
| Q3 2021 | $2,132,000 | -18.2% | 112,820 | -19.5% | 0.00% | -100.0% |
| Q2 2021 | $2,606,000 | -20.3% | 140,169 | -2.5% | 0.00% | 0.0% |
| Q1 2021 | $3,271,000 | +140.2% | 143,735 | +129.1% | 0.00% | – |
| Q4 2020 | $1,362,000 | +196.7% | 62,746 | +37.3% | 0.00% | – |
| Q3 2020 | $459,000 | +92.9% | 45,687 | +48.9% | 0.00% | – |
| Q2 2020 | $238,000 | +9.2% | 30,675 | +42.9% | 0.00% | – |
| Q1 2020 | $218,000 | +2.3% | 21,462 | +10.5% | 0.00% | – |
| Q4 2019 | $213,000 | +67.7% | 19,421 | +39.4% | 0.00% | – |
| Q3 2019 | $127,000 | -2.3% | 13,935 | +21.3% | 0.00% | – |
| Q2 2019 | $130,000 | +242.1% | 11,484 | +240.7% | 0.00% | – |
| Q1 2019 | $38,000 | +26.7% | 3,371 | +2.2% | 0.00% | – |
| Q4 2018 | $30,000 | – | 3,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |